CTLA4 FUSION PROTEINS FOR THE TREATMENT OF DIABETES

• 收藏
• 分享

专利权人:

DMNoMore

发明人:

Tihamer Orban

申请号：

US16356445

公开号：

US20190211105A1

申请日:

2019.03.18

申请国别(地区):

US

年份:

2019

代理人:

摘要：

A method of treating, preventing, or delaying the progression of Type 1 diabetes mellitus autoimmunity by administering an effective amount of a cytotoxic T-lymphocyte-associated antigen 4 (CTLA4) molecule is provided herewith. The CTLA4 molecule may be a fusion protein of a CTLA4 extracellular region and an immunoglobulin, such as abatacept.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/